tiprankstipranks
Trending News
More News >
United Therapeutics Shareholders Approve Key Resolutions
PremiumCompany AnnouncementsUnited Therapeutics Shareholders Approve Key Resolutions
12d ago
United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
Premium
Company Announcements
United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
12d ago
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
Premium
Ratings
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
13d ago
United Therapeutics: Strong Market Position and Growth Potential Amidst Emerging Competition
PremiumRatingsUnited Therapeutics: Strong Market Position and Growth Potential Amidst Emerging Competition
28d ago
United Therapeutics price target lowered to $315 from $321 at BofA
Premium
The Fly
United Therapeutics price target lowered to $315 from $321 at BofA
28d ago
Morning Movers: Insmed jumps, United Therapeutics falls after TPIP study results
Premium
The Fly
Morning Movers: Insmed jumps, United Therapeutics falls after TPIP study results
29d ago
Maintaining Market Position: United Therapeutics’ Tyvaso DPI Amidst Competition and Future Growth Prospects
PremiumRatingsMaintaining Market Position: United Therapeutics’ Tyvaso DPI Amidst Competition and Future Growth Prospects
1M ago
Liquidia price target raised to $23 from $20 at Wells Fargo
Premium
The Fly
Liquidia price target raised to $23 from $20 at Wells Fargo
1M ago
Hold Rating for United Therapeutics Amid Competitive Pressures from LQDA’s Yutrepia
Premium
Ratings
Hold Rating for United Therapeutics Amid Competitive Pressures from LQDA’s Yutrepia
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100